Novel Collaborative Care Approach Shows Promise in Treating Youth with Persistent Post-Concussive Symptoms

On Dec. 26, 2018, 18-year-old Hannah Nash, an avid basketball player, was hit in the head while at basketball practice. She initially felt a sharp pain and her head felt foggy. She recalled leaving practice abruptly. The next day, she played in a game, but she didn’t feel like herself. “I played terribly,” Nash said. […]

Read More →

Light and Genetic Probes Untangle Dynamics of Blood Flow Through the Brain’s Vast Capillary Network

While the human brain has over 400 miles of total vasculature, little is known about the tiny capillaries that make up much of this intricate labyrinth of blood vessels critical for delivering oxygenated blood and nutrients to billions of brain cells. According to Dr. Andy Shih, a principal investigator in the Center for Developmental Biology […]

Read More →

How the OBCC Team Is Stepping Up, and Out, to Help During the Pandemic

When the economic and social impacts of the coronavirus pandemic began taking root in early spring 2020, the team at Seattle Children’s Odessa Brown Children’s Clinic (OBCC) immediately anticipated the devastation and hardship it would bring. “From the start, we recognized that the families we serve were being disproportionally negatively impacted by the virus itself, […]

Read More →

Cancer Research at Seattle Children’s Contributes to FDA Approval of CAR T-Cell Immunotherapy Treatment for Adults with Relapsed or Refractory Large B-Cell Lymphoma

The U.S. Food and Drug Administration on Feb. 5 approved Bristol Myers Squibb’s Breyanzi, a chimeric antigen receptor (CAR) T-cell therapy used to treat adults with certain types of large B-cell lymphoma who have not responded to or who have relapsed after standard treatments. The approval was supported by research at Seattle Children’s, including the […]

Read More →

Addressing Vaccine Hesitancy: Experts Answer Important COVID-19 Vaccine Questions

In December 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for COVID-19 vaccines developed by Pfizer-BioNTech and Moderna. This was hailed as a turning point in the COVID-19 pandemic. Still, many people are hesitant about these new vaccines for a variety of reasons, and the proliferation of misinformation can make […]

Read More →

Seattle Children’s Anti-Racism Organizational Change Plan

[smartslider3 slider=6] Seattle Children’s is dedicated to becoming an anti-racist and equitable health organization. To realize this vision, we’ve adopted a long-term comprehensive plan with our Anti-Racism Organizational Change and Accelerated Equity, Diversity and Inclusion Plan. This plan was designed with the guidance and support from our patients, workforce, community and trusted expert leaders on […]

Read More →

Liquid Biopsy Promising in Children With Vascular Malformations

Doctors at Seattle Children’s are investigating whether a simple liquid biopsy containing a small amount of fluid from a patient may someday provide an easier route to a genetic diagnosis in children with vascular or lymphatic malformations. The work is a collaborative effort led by Dr. James Bennett, a clinical geneticist and co-director of the […]

Read More →